ArticleRheumatology and immunology research2026
Hospital-based first diagnoses of systemic sclerosis: Defining initial clinical presentations and diagnostic pathways.
Article in Rheumatology and immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Early diagnosis of systemic sclerosis (SSc) is challenging due to heterogeneous presentation and lack of reliable biomarkers, resulting in many patients being diagnosed during hospitalization with advanced disease and severe complications. We aimed to characterize the clinical presentation, diagnostic pathway, and outcomes of patients first diagnosed with SSc during hospitalization. Methods: We retrospectively reviewed adult patients newly diagnosed with SSc during hospitalization (January 2016-July 2023), including those referred for SSc evaluation or with SSc features identified during admission for other diagnoses. Patients previously diagnosed as outpatients were excluded. Clinical presentations were compared between patients admitted for SSc-related reasons Results: Thirty-five patients were included (mean age 60.4 ± 12.8 years; 60% women). Most (68.6%) were incidentally diagnosed with SSc during hospitalization for unrelated conditions. Common indications for hospitalization included pericardial effusion (22.9%), progressive pulmonary hypertension (17.1%), and progressive interstitial lung disease (14.3%). Approximately 60% of both hospitalized patients in both groups initially saw general practitioners before were rheumatological referral. Age, sex, symptom duration, most clinical features, length of stay, hospital costs, and outcomes were similar between patients admitted for SSC-related Conclusion: Hospitalized patients first diagnosed with SSc predominantly present with diffuse cutaneous involvement and advanced cardiopulmonary complications. Most cases are identified during hospitalization for unrelated conditions, highlighting the need for increased clinical vigilance and systematic SSc evaluation in at-risk hospitalized patients to enable early detection and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.